Camlin Fine Sciences Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Ashish Dandekar
Chief executive officer
₹28.2m
Total compensation
| CEO salary percentage | 54.61% |
| CEO tenure | 18.8yrs |
| CEO ownership | 15.5% |
| Management average tenure | 4.2yrs |
| Board average tenure | 5.2yrs |
Recent management updates
This Is Why Camlin Fine Sciences Limited's (NSE:CAMLINFINE) CEO Compensation Looks Appropriate
Aug 02
Recent updates
A Look At The Intrinsic Value Of Camlin Fine Sciences Limited (NSE:CAMLINFINE)
Sep 30The Price Is Right For Camlin Fine Sciences Limited (NSE:CAMLINFINE) Even After Diving 31%
Aug 14This Is Why Camlin Fine Sciences Limited's (NSE:CAMLINFINE) CEO Compensation Looks Appropriate
Aug 02Revenues Tell The Story For Camlin Fine Sciences Limited (NSE:CAMLINFINE) As Its Stock Soars 49%
Jun 26Is Camlin Fine Sciences (NSE:CAMLINFINE) A Risky Investment?
Jun 16Investors Shouldn't Be Too Comfortable With Camlin Fine Sciences' (NSE:CAMLINFINE) Earnings
May 31There's Reason For Concern Over Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Massive 25% Price Jump
May 10The Market Lifts Camlin Fine Sciences Limited (NSE:CAMLINFINE) Shares 29% But It Can Do More
Feb 25At ₹141, Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Worth Looking At Closely?
Feb 11Investors Could Be Concerned With Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital
Jan 21A Piece Of The Puzzle Missing From Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 26% Share Price Climb
Nov 27Camlin Fine Sciences (NSE:CAMLINFINE) Will Be Hoping To Turn Its Returns On Capital Around
Oct 19Camlin Fine Sciences (NSE:CAMLINFINE) Has A Somewhat Strained Balance Sheet
Mar 29Positive Sentiment Still Eludes Camlin Fine Sciences Limited (NSE:CAMLINFINE) Following 26% Share Price Slump
Mar 29Is There An Opportunity With Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 31% Undervaluation?
Sep 02Is It Time To Consider Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE)?
Apr 06Rainbows and Unicorns: Camlin Fine Sciences Limited (NSE:CAMLINFINE) Analysts Just Became A Lot More Optimistic
Feb 19Camlin Fine Sciences Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Nov 17Should You Think About Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE) Now?
Oct 15Camlin Fine Sciences Limited (NSE:CAMLINFINE) Shares Could Be 32% Below Their Intrinsic Value Estimate
Jan 15Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Paint A Concerning Picture
Jan 04Why Camlin Fine Sciences Limited (NSE:CAMLINFINE) Could Be Worth Watching
Nov 30Investors Could Be Concerned With Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital
Oct 05At ₹163, Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Worth Looking At Closely?
Aug 20Estimating The Intrinsic Value Of Camlin Fine Sciences Limited (NSE:CAMLINFINE)
Jun 30Camlin Fine Sciences (NSE:CAMLINFINE) Takes On Some Risk With Its Use Of Debt
Feb 26CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | ₹187m |
| Jun 30 2025 | n/a | n/a | ₹825m |
| Mar 31 2025 | ₹28m | ₹15m | ₹685m |
| Dec 31 2024 | n/a | n/a | -₹2b |
| Sep 30 2024 | n/a | n/a | -₹2b |
| Jun 30 2024 | n/a | n/a | -₹1b |
| Mar 31 2024 | ₹29m | ₹15m | ₹651m |
| Dec 31 2023 | n/a | n/a | -₹8m |
| Sep 30 2023 | n/a | n/a | ₹350m |
| Jun 30 2023 | n/a | n/a | ₹674m |
| Mar 31 2023 | ₹26m | ₹14m | ₹577m |
| Dec 31 2022 | n/a | n/a | ₹581m |
| Sep 30 2022 | n/a | n/a | ₹628m |
| Jun 30 2022 | n/a | n/a | ₹442m |
| Mar 31 2022 | ₹20m | ₹12m | ₹650m |
| Dec 31 2021 | n/a | n/a | ₹598m |
| Sep 30 2021 | n/a | n/a | ₹465m |
| Jun 30 2021 | n/a | n/a | ₹579m |
| Mar 31 2021 | ₹18m | ₹11m | ₹510m |
| Dec 31 2020 | n/a | n/a | ₹394m |
| Sep 30 2020 | n/a | n/a | ₹291m |
| Jun 30 2020 | n/a | n/a | ₹302m |
| Mar 31 2020 | ₹18m | ₹11m | ₹303m |
| Dec 31 2019 | n/a | n/a | ₹349m |
| Sep 30 2019 | n/a | n/a | ₹277m |
| Jun 30 2019 | n/a | n/a | ₹221m |
| Mar 31 2019 | ₹18m | ₹11m | ₹6m |
Compensation vs Market: Ashish's total compensation ($USD318.47K) is about average for companies of similar size in the Indian market ($USD293.52K).
Compensation vs Earnings: Ashish's compensation has been consistent with company performance over the past year.
CEO
Ashish Dandekar (61 yo)
Mr. Ashish Subhash Dandekar serves as the Chairman of Board at Camlin Fine Sciences Limited since June 17, 2021. He has been the Managing Director of Camlin Fine Sciences Limited (formerly known as Camlin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | no data | ₹28.22m | 15.5% ₹ 4.8b | |
| MD & Director | 4.4yrs | ₹24.56m | 1.92% ₹ 599.7m | |
| Executive Director of Technical & Executive Director | no data | ₹11.98m | 0.10% ₹ 32.4m | |
| Chief Financial Officer | 8.8yrs | no data | no data | |
| Chief Operating Officer | 1.9yrs | no data | no data | |
| Company Secretary | 4yrs | ₹1.39m | no data | |
| Global Head of IT | no data | no data | no data | |
| Management Consultant | no data | no data | no data |
Experienced Management: CAMLINFINE's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 18.8yrs | ₹28.22m | 15.5% ₹ 4.8b | |
| MD & Director | 11.3yrs | ₹24.56m | 1.92% ₹ 599.7m | |
| Executive Director of Technical & Executive Director | 7.4yrs | ₹11.98m | 0.10% ₹ 32.4m | |
| Independent Director | less than a year | ₹600.00k | 0.070% ₹ 21.8m | |
| Non-Executive Non-Independent Director | 5.3yrs | no data | no data | |
| Non-Executive Independent Director | 4.1yrs | ₹2.45m | no data | |
| Non-Executive Non-Independent Director | 8.1yrs | ₹700.00k | 1.61% ₹ 501.8m | |
| Independent Director | 5.2yrs | ₹2.46m | no data | |
| Independent Non-Executive Director | 4.9yrs | ₹2.64m | 0.0032% ₹ 996.9k | |
| Independent Director | 6.3yrs | ₹2.18m | no data | |
| Independent Director | less than a year | ₹125.00k | no data | |
| Non-Executive Non-Independent Director | less than a year | no data | no data |
Experienced Board: CAMLINFINE's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/17 08:05 |
| End of Day Share Price | 2025/11/14 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Camlin Fine Sciences Limited is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ankur Periwal | Axis Capital Limited |
| Abhishek Navalgund | Centrum Broking Limited |
| Satish Kumar | CGS International |